Display options
Cite
Garg AD, Galluzzi L, Apetoh L, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol. 2015;6:588doi: 10.3389/fimmu.2015.00588.
Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., Coosemans, A., Coulie, P. G., De Ruysscher, D., Dini, L., de Witte, P., Dudek-Peric, A. M., Faggioni, A., Fucikova, J., Gaipl, U. S., Golab, J., Gougeon, M. L., Hamblin, M. R., Hemminki, A., Herrmann, M., Hodge, J. W., Kepp, O., Kroemer, G., Krysko, D. V., Land, W. G., Madeo, F., Manfredi, A. A., Mattarollo, S. R., Maueroder, C., Merendino, N., Multhoff, G., Pabst, T., Ricci, J. E., Riganti, C., Romano, E., Rufo, N., Smyth, M. J., Sonnemann, J., Spisek, R., Stagg, J., Vacchelli, E., Vandenabeele, P., Vandenberk, L., Van den Eynde, B. J., Van Gool, S., Velotti, F., Zitvogel, L., & Agostinis, P. (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in immunology, 6588. https://doi.org/10.3389/fimmu.2015.00588
Garg, Abhishek D, et al. "Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death." Frontiers in immunology vol. 6 (2015): 588. doi: https://doi.org/10.3389/fimmu.2015.00588
Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, Dudek-Peric AM, Faggioni A, Fucikova J, Gaipl US, Golab J, Gougeon ML, Hamblin MR, Hemminki A, Herrmann M, Hodge JW, Kepp O, Kroemer G, Krysko DV, Land WG, Madeo F, Manfredi AA, Mattarollo SR, Maueroder C, Merendino N, Multhoff G, Pabst T, Ricci JE, Riganti C, Romano E, Rufo N, Smyth MJ, Sonnemann J, Spisek R, Stagg J, Vacchelli E, Vandenabeele P, Vandenberk L, Van den Eynde BJ, Van Gool S, Velotti F, Zitvogel L, Agostinis P. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Front Immunol. 2015 Nov 20;6:588. doi: 10.3389/fimmu.2015.00588. eCollection 2015. PMID: 26635802; PMCID: PMC4653610.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2015 Nov 20;6:588. doi: 10.3389/fimmu.2015.00588. eCollection 2015.

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.

Frontiers in immunology

Abhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone, An Coosemans, Pierre G Coulie, Dirk De Ruysscher, Luciana Dini, Peter de Witte, Aleksandra M Dudek-Peric, Alberto Faggioni, Jitka Fucikova, Udo S Gaipl, Jakub Golab, Marie-Lise Gougeon, Michael R Hamblin, Akseli Hemminki, Martin Herrmann, James W Hodge, Oliver Kepp, Guido Kroemer, Dmitri V Krysko, Walter G Land, Frank Madeo, Angelo A Manfredi, Stephen R Mattarollo, Christian Maueroder, Nicolò Merendino, Gabriele Multhoff, Thomas Pabst, Jean-Ehrland Ricci, Chiara Riganti, Erminia Romano, Nicole Rufo, Mark J Smyth, Jürgen Sonnemann, Radek Spisek, John Stagg, Erika Vacchelli, Peter Vandenabeele, Lien Vandenberk, Benoit J Van den Eynde, Stefaan Van Gool, Francesca Velotti, Laurence Zitvogel, Patrizia Agostinis

Affiliations

  1. Cell Death Research and Therapy Laboratory, Department of Cellular Molecular Medicine, KU Leuven?-?University of Leuven , Leuven , Belgium.
  2. Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Université Paris Descartes, Sorbonne Paris Cité , Paris , France ; Université Pierre et Marie Curie , Paris , France ; Gustave Roussy Comprehensive Cancer Institute , Villejuif , France.
  3. U866, INSERM , Dijon , France ; Faculté de Médecine, Université de Bourgogne , Dijon , France ; Centre Georges François Leclerc , Dijon , France.
  4. Department of Gynaecology and Obstetrics, UZ Leuven , Leuven , Belgium ; Laboratory of Gynaecologic Oncology, Department of Oncology, Leuven Cancer Institute, KU Leuven , Leuven , Belgium.
  5. Department of Microbiology, Biochemistry, and Molecular Genetics, University Hospital Cancer Center, Rutgers Cancer Institute of New Jersey, New Jersey Medical School , Newark, NJ , USA.
  6. Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel , Jette , Belgium.
  7. Faculty of Life Sciences, University of Manchester , Manchester , UK.
  8. Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nurnberg , Erlangen , Germany.
  9. Department of Experimental Medicine, Sapienza University of Rome , Rome , Italy.
  10. de Duve Institute, Université Catholique de Louvain , Brussels , Belgium.
  11. Department of Radiation Oncology, University Hospitals Leuven, KU Leuven?-?University of Leuven , Leuven , Belgium.
  12. Department of Biological and Environmental Science and Technology, University of Salento , Salento , Italy.
  13. Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven?-?University of Leuven , Leuven , Belgium.
  14. Sapienza University of Rome , Rome , Italy.
  15. SOTIO , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.
  16. Department of Radiation Oncology, Universitätsklinikum Erlangen , Erlangen , Germany.
  17. Department of Immunology, Medical University of Warsaw , Warsaw , Poland.
  18. Biotherapy and Vaccine Unit, Institut Pasteur , Paris , France.
  19. Wellman Center for Photomedicine, Massachusetts General Hospital , Boston, MA , USA.
  20. Cancer Gene Therapy Group, Transplantation Laboratory, Haartman Institute, University of Helsinki , Helsinki , Finland ; Helsinki University Hospital Comprehensive Cancer Center , Helsinki , Finland ; TILT Biotherapeutics Ltd. , Helsinki , Finland.
  21. Recombinant Vaccine Group, Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.
  22. Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Université Paris Descartes, Sorbonne Paris Cité , Paris , France ; Université Pierre et Marie Curie , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif , France.
  23. Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Université Paris Descartes, Sorbonne Paris Cité , Paris , France ; Université Pierre et Marie Curie , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute , Villejuif , France ; Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP , Paris , France ; Department of Women's and Children's Health, Karolinska University Hospital , Stockholm , Sweden.
  24. Molecular Signaling and Cell Death Unit, Inflammation Research Center, VIB , Ghent , Belgium ; Department of Biomedical Molecular Biology, Ghent University , Ghent , Belgium.
  25. Molecular ImmunoRheumatology, INSERM UMRS1109, Laboratory of Excellence Transplantex, University of Strasbourg , Strasbourg , France.
  26. Institute of Molecular Biosciences, NAWI Graz, University of Graz , Graz , Austria ; BioTechMed Graz , Graz , Austria.
  27. IRRCS Istituto Scientifico San Raffaele, Università Vita-Salute San Raffaele , Milan , Italy.
  28. Translational Research Institute, University of Queensland Diamantina Institute, University of Queensland , Wooloongabba, QLD , Australia.
  29. Laboratory of Cellular and Molecular Nutrition, Department of Ecological and Biological Sciences, Tuscia University , Viterbo , Italy.
  30. Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München , Munich , Germany.
  31. Department of Medical Oncology, University Hospital , Bern , Switzerland.
  32. INSERM, U1065, Université de Nice-Sophia-Antipolis, Centre Méditerranéen de Médecine Moléculaire (C3M), Équipe "Contrôle Métabolique des Morts Cellulaires" , Nice , France.
  33. Department of Oncology, University of Turin , Turin , Italy.
  34. Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Insitute , Herston, QLD , Australia ; School of Medicine, University of Queensland , Herston, QLD , Australia.
  35. Department of Paediatric Haematology and Oncology, Children's Clinic, Jena University Hospital , Jena , Germany.
  36. Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Faculté de Pharmacie, Université de Montréal , Montreal, QC , Canada.
  37. Laboratory of Pediatric Immunology, Department of Microbiology and Immunology, KU Leuven?-?University of Leuven , Leuven , Belgium.
  38. Ludwig Institute for Cancer Research, de Duve Institute, Université Catholique de Louvain , Brussels , Belgium.
  39. Department of Ecological and Biological Sciences, Tuscia University , Viterbo , Italy.
  40. Gustave Roussy Comprehensive Cancer Institute , Villejuif , France ; University of Paris Sud , Le Kremlin-Bicêtre , France ; U1015, INSERM , Villejuif , France ; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 507 , Villejuif , France.

PMID: 26635802 PMCID: PMC4653610 DOI: 10.3389/fimmu.2015.00588

Abstract

The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by cells succumbing to immunogenic cell death (ICD) favors the establishment of a productive interface with the immune system. This results in the elicitation of tumor-targeting immune responses associated with the elimination of residual, treatment-resistant cancer cells, as well as with the establishment of immunological memory. Although ICD has been characterized with increased precision since its discovery, several questions remain to be addressed. Here, we summarize and tabulate the main molecular, immunological, preclinical, and clinical aspects of ICD, in an attempt to capture the essence of this phenomenon, and identify future challenges for this rapidly expanding field of investigation.

Keywords: anti-tumor immunity; immunogenicity; immunotherapy; molecular medicine; oncoimmunology; patient prognosis; translational medicine

References

  1. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2233-8 - PubMed
  2. Cancer Res. 1999 Apr 15;59(8):1941-6 - PubMed
  3. J Immunother. 1999 Sep;22(5):415-22 - PubMed
  4. Radiology. 1976 Jan;118(1):211-8 - PubMed
  5. J Biochem. 2001 Mar;129(3):445-54 - PubMed
  6. Cell Death Differ. 2000 Oct;7(10):911-5 - PubMed
  7. Cancer Res. 2002 Mar 15;62(6):1884-9 - PubMed
  8. Science. 2002 Apr 12;296(5566):301-5 - PubMed
  9. Nature. 2002 Jul 11;418(6894):191-5 - PubMed
  10. Cell Growth Differ. 2002 Sep;13(9):449-55 - PubMed
  11. Immunol Cell Biol. 2003 Apr;81(2):106-13 - PubMed
  12. Cell. 2003 Jun 13;113(6):717-30 - PubMed
  13. Nature. 2003 Oct 2;425(6957):516-21 - PubMed
  14. Mol Biol Cell. 2004 Mar;15(3):1089-100 - PubMed
  15. J Immunol. 2004 Mar 1;172(5):2731-8 - PubMed
  16. J Leukoc Biol. 2004 Jun;75(6):995-1000 - PubMed
  17. Gene Ther. 2004 Jul;11(13):1099-104 - PubMed
  18. J Biol Chem. 2004 Jun 25;279(26):27320-6 - PubMed
  19. Nat Rev Immunol. 2004 Jun;4(6):469-78 - PubMed
  20. Cell Death Differ. 2004 Oct;11(10):1133-45 - PubMed
  21. Rheumatology (Oxford). 2005 Jan;44(1):32-9 - PubMed
  22. J Exp Med. 2004 Nov 1;200(9):1157-65 - PubMed
  23. Cancer Res. 2004 Nov 1;64(21):7985-94 - PubMed
  24. J Leukoc Biol. 2005 Mar;77(3):361-8 - PubMed
  25. J Immunol. 2005 Jan 1;174(1):90-8 - PubMed
  26. Exp Hematol. 2005 Jan;33(1):73-84 - PubMed
  27. Cancer Res. 2005 Feb 1;65(3):1018-26 - PubMed
  28. Immunity. 2005 Mar;22(3):275-84 - PubMed
  29. Blood. 2005 Jul 15;106(2):609-16 - PubMed
  30. J Biol Chem. 2005 Jun 17;280(24):23349-55 - PubMed
  31. Shock. 2005 Jun;23(6):533-8 - PubMed
  32. Cancer Treat Rev. 2005 May;31(3):159-72 - PubMed
  33. Cell Death Differ. 2005 Nov;12(11):1442-4 - PubMed
  34. Cancer Res. 2005 Jun 15;65(12):5238-47 - PubMed
  35. Cell Signal. 2006 Mar;18(3):328-35 - PubMed
  36. Cell. 2005 Oct 21;123(2):321-34 - PubMed
  37. J Exp Med. 2005 Dec 19;202(12):1691-701 - PubMed
  38. J Immunol. 2006 Apr 15;176(8):4757-65 - PubMed
  39. Surg Oncol. 2006 Jul;15(1):25-8 - PubMed
  40. Immunity. 2006 Aug;25(2):261-70 - PubMed
  41. Blood. 2006 Nov 15;108(10):3580-9 - PubMed
  42. Nat Rev Immunol. 2006 Oct;6(10):715-27 - PubMed
  43. J Natl Cancer Inst. 2006 Sep 20;98(18):1292-301 - PubMed
  44. J Leukoc Biol. 2007 Jan;81(1):1-5 - PubMed
  45. J Immunol. 2006 Dec 1;177(11):7849-57 - PubMed
  46. Cell Death Differ. 2007 Apr;14(4):733-42 - PubMed
  47. Nat Med. 2007 Jan;13(1):54-61 - PubMed
  48. Pathol Int. 2007 Jan;57(1):1-11 - PubMed
  49. Blood. 2007 Jun 1;109(11):4839-45 - PubMed
  50. Cell Death Differ. 2007 Jun;14(6):1117-28 - PubMed
  51. Biochimie. 2007 Sep;89(9):1089-106 - PubMed
  52. J Immunol. 2007 May 1;178(9):5727-34 - PubMed
  53. Cell Death Differ. 2007 Oct;14(10):1848-50 - PubMed
  54. Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4647-51 - PubMed
  55. Nat Med. 2007 Sep;13(9):1050-9 - PubMed
  56. Trends Immunol. 2007 Oct;28(10):429-36 - PubMed
  57. Br J Cancer. 2007 Nov 19;97(10):1381-7 - PubMed
  58. Cell Death Differ. 2008 Feb;15(2):274-82 - PubMed
  59. Photochem Photobiol. 2008 May-Jun;84(3):779-85 - PubMed
  60. J Immunol. 2008 Mar 15;180(6):4299-307 - PubMed
  61. Curr Mol Med. 2007 Dec;7(8):711-24 - PubMed
  62. Cell Death Differ. 2008 Sep;15(9):1499-509 - PubMed
  63. Immunity. 2008 Jul 18;29(1):21-32 - PubMed
  64. Cell Death Differ. 2009 Jan;16(1):175-83 - PubMed
  65. Cancer Immunol Immunother. 2009 Aug;58(8):1219-28 - PubMed
  66. Immunity. 2008 Dec 19;29(6):835-8 - PubMed
  67. Curr Opin Oncol. 2009 Jan;21(1):71-6 - PubMed
  68. EMBO J. 2009 Mar 4;28(5):578-90 - PubMed
  69. Int J Cancer. 2009 May 15;124(10):2450-9 - PubMed
  70. Cell Cycle. 2009 Feb 15;8(4):639-42 - PubMed
  71. Nat Rev Cancer. 2009 Apr;9(4):302-12 - PubMed
  72. Nat Rev Immunol. 2009 May;9(5):353-63 - PubMed
  73. J Biol Chem. 2009 Sep 4;284(36):24035-48 - PubMed
  74. Biochim Biophys Acta. 2010 Jan;1805(1):53-71 - PubMed
  75. Nature. 2009 Sep 10;461(7261):282-6 - PubMed
  76. Nat Med. 2009 Oct;15(10):1170-8 - PubMed
  77. Clin Orthop Relat Res. 1991 Jan;(262):3-11 - PubMed
  78. Apoptosis. 2010 Feb;15(2):139-52 - PubMed
  79. Oncogene. 2010 Jan 28;29(4):482-91 - PubMed
  80. Mol Cancer. 2009 Nov 19;8:108 - PubMed
  81. J Immunol. 2010 Jan 15;184(2):1022-30 - PubMed
  82. Curr Opin Pharmacol. 2010 Apr;10(2):185-90 - PubMed
  83. J Immunol. 2010 Mar 1;184(5):2655-62 - PubMed
  84. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2574-9 - PubMed
  85. PLoS One. 2010 Feb 08;5(2):e9103 - PubMed
  86. Nature. 2010 Mar 4;464(7285):104-7 - PubMed
  87. J Immunotoxicol. 2010 Jul-Sep;7(3):194-204 - PubMed
  88. Apoptosis. 2010 Sep;15(9):1050-71 - PubMed
  89. Ann N Y Acad Sci. 2010 Feb;1189:127-32 - PubMed
  90. Cell. 2010 Mar 19;140(6):798-804 - PubMed
  91. J Immunol. 2010 May 1;184(9):4936-46 - PubMed
  92. Biochem Biophys Res Commun. 2010 Jul 30;398(3):525-31 - PubMed
  93. Cancer Res. 2010 Nov 15;70(22):9062-72 - PubMed
  94. J Am Acad Dermatol. 2010 Dec;63(6):984-90 - PubMed
  95. Oncogene. 2011 Mar 10;30(10):1147-58 - PubMed
  96. Cancer Res. 2011 Feb 1;71(3):768-78 - PubMed
  97. Circ Res. 2011 Jan 21;108(2):235-48 - PubMed
  98. Photochem Photobiol Sci. 2011 May;10(5):670-80 - PubMed
  99. Photochem Photobiol Sci. 2011 May;10(5):664-9 - PubMed
  100. Cell Death Differ. 2011 Aug;18(8):1316-25 - PubMed
  101. J Exp Med. 2011 Mar 14;208(3):491-503 - PubMed
  102. Oncogene. 2011 Oct 20;30(42):4297-306 - PubMed
  103. Int Rev Immunol. 2011 Apr-Jun;30(2-3):150-82 - PubMed
  104. Cancer Res. 2011 Jul 15;71(14):4821-33 - PubMed
  105. CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81 - PubMed
  106. Arch Virol. 2011 Aug;156(8):1335-44 - PubMed
  107. Cancer Immunol Immunother. 2011 Oct;60(10):1431-7 - PubMed
  108. Cancer Res. 2011 Jul 15;71(14):4809-20 - PubMed
  109. Hepatology. 2011 Sep 2;54(3):999-1008 - PubMed
  110. J Immunol. 2011 Aug 15;187(4):1626-33 - PubMed
  111. Cancer Immunol Immunother. 2011 Oct;60(10):1503-7 - PubMed
  112. Int J Cancer. 2012 Jun 1;130(11):2607-17 - PubMed
  113. Cell Microbiol. 2012 Jan;14(1):133-46 - PubMed
  114. J Immunol. 2011 Nov 15;187(10):4954-66 - PubMed
  115. Photodiagnosis Photodyn Ther. 2011 Dec;8(4):291-6 - PubMed
  116. Science. 2011 Dec 16;334(6062):1573-7 - PubMed
  117. J Exp Med. 2012 Jan 16;209(1):157-71 - PubMed
  118. Cancer Immunol Immunother. 2012 Feb;61(2):215-221 - PubMed
  119. EMBO J. 2012 Mar 7;31(5):1062-79 - PubMed
  120. EMBO J. 2012 Mar 7;31(5):1055-7 - PubMed
  121. Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33 - PubMed
  122. Nat Rev Cancer. 2012 Mar 01;12(4):307-13 - PubMed
  123. Nat Med. 2012 Mar 06;18(3):344-6; author reply 346 - PubMed
  124. Cancer Res. 2012 May 1;72(9):2327-38 - PubMed
  125. PLoS One. 2012;7(3):e31732 - PubMed
  126. Nat Rev Cancer. 2012 Mar 15;12(4):298-306 - PubMed
  127. Nat Rev Cancer. 2012 Mar 22;12(4):252-64 - PubMed
  128. Trends Immunol. 2012 Jul;33(7):364-72 - PubMed
  129. Cancer Res. 2012 May 15;72(10):2609-21 - PubMed
  130. Immunity. 2012 Apr 20;36(4):635-45 - PubMed
  131. Immunity. 2012 Apr 20;36(4):646-57 - PubMed
  132. Cancer Immunol Immunother. 2012 Nov;61(11):1989-2002 - PubMed
  133. Breast Cancer Res. 2012 Apr 26;14(2):R68 - PubMed
  134. Cancer Res. 2012 Jul 1;72(13):3290-301 - PubMed
  135. Cancer Res. 2012 Aug 15;72(16):3967-76 - PubMed
  136. Cell Death Differ. 2012 Nov;19(11):1880-91 - PubMed
  137. Sci Transl Med. 2012 Jul 18;4(143):143ra99 - PubMed
  138. Nat Immunol. 2012 Sep;13(9):832-42 - PubMed
  139. J Exp Med. 2012 Aug 27;209(9):1519-28 - PubMed
  140. J Immunol. 2012 Sep 15;189(6):3209-20 - PubMed
  141. Oncoimmunology. 2012 Aug 1;1(5):786-788 - PubMed
  142. Int J Mol Sci. 2012;13(8):9877-92 - PubMed
  143. Science. 2012 Sep 28;337(6102):1678-84 - PubMed
  144. Nat Rev Cancer. 2012 Dec;12(12):860-75 - PubMed
  145. Annu Rev Immunol. 2013;31:51-72 - PubMed
  146. Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8 - PubMed
  147. PLoS One. 2012;7(12):e50811 - PubMed
  148. Autophagy. 2013 Apr;9(4):615-6 - PubMed
  149. Int J Cancer. 2013 Aug 1;133(3):624-36 - PubMed
  150. Cytokine Growth Factor Rev. 2013 Aug;24(4):319-33 - PubMed
  151. BMC Cancer. 2013 Apr 03;13:177 - PubMed
  152. Immunity. 2013 Apr 18;38(4):729-41 - PubMed
  153. Cell Stress Chaperones. 2013 Nov;18(6):801-8 - PubMed
  154. PLoS One. 2013 Apr 12;8(4):e60975 - PubMed
  155. PLoS One. 2013 Apr 30;8(4):e62449 - PubMed
  156. Cell Death Differ. 2014 Jan;21(1):26-38 - PubMed
  157. PLoS One. 2013 Jun 07;8(6):e65181 - PubMed
  158. Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6 - PubMed
  159. Autophagy. 2013 Sep;9(9):1292-307 - PubMed
  160. Cell Death Differ. 2014 Jan;21(1):69-78 - PubMed
  161. Eur J Immunol. 2013 Oct;43(10):2718-29 - PubMed
  162. Cell Death Differ. 2014 Jan;21(1):79-91 - PubMed
  163. Immunity. 2013 Jul 25;39(1):11-26 - PubMed
  164. Oncoimmunology. 2013 Jun 1;2(6):e24612 - PubMed
  165. Biofactors. 2013 Jul-Aug;39(4):355-67 - PubMed
  166. Semin Cancer Biol. 2013 Oct;23(5):380-90 - PubMed
  167. Cell Death Dis. 2013 Oct 03;4:e826 - PubMed
  168. Cancer Res. 2013 Dec 15;73(24):7265-76 - PubMed
  169. Cancer Immunol Immunother. 1986;22(2):119-24 - PubMed
  170. Science. 2013 Nov 22;342(6161):971-6 - PubMed
  171. Front Immunol. 2013 Dec 11;4:438 - PubMed
  172. Nat Rev Cancer. 2014 Feb;14(2):135-46 - PubMed
  173. Oncotarget. 2014 Jan 30;5(2):403-16 - PubMed
  174. Photochem Photobiol Sci. 2014 Mar;13(3):474-87 - PubMed
  175. Int J Cancer. 2014 Sep 1;135(5):1165-77 - PubMed
  176. Sci Transl Med. 2014 Mar 5;6(226):226ra32 - PubMed
  177. Cancer J. 2014 Mar-Apr;20(2):151-5 - PubMed
  178. Int Immunopharmacol. 2014 Jun;20(2):359-65 - PubMed
  179. Oncoimmunology. 2014 Jan 1;3(1):e27884 - PubMed
  180. Lancet Oncol. 2014 Jun;15(7):e257-67 - PubMed
  181. Int J Cancer. 2015 Feb 15;136(4):945-54 - PubMed
  182. Cell Death Differ. 2014 Dec;21(12):1825-37 - PubMed
  183. Oncoimmunology. 2014 Apr 16;3:e28473 - PubMed
  184. Oncoimmunology. 2014 Apr 25;3:e28518 - PubMed
  185. Nat Cell Biol. 2014 Aug;16(8):728-36 - PubMed
  186. PLoS One. 2014 Aug 20;9(8):e105778 - PubMed
  187. Oncotarget. 2014 Aug 15;5(15):6526-39 - PubMed
  188. Diabetes. 2015 Feb;64(2):573-86 - PubMed
  189. Int J Cancer. 2015 Mar 1;136(5):E313-25 - PubMed
  190. Nutrition. 2015 Apr;31(4):578-81 - PubMed
  191. Cell Death Differ. 2015 Jan;22(1):58-73 - PubMed
  192. Parasite Immunol. 2015 May;37(5):267-73 - PubMed
  193. PLoS One. 2014 Oct 23;9(10):e110826 - PubMed
  194. Nat Med. 2014 Nov;20(11):1301-9 - PubMed
  195. Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52 - PubMed
  196. Front Immunol. 2014 Nov 11;5:560 - PubMed
  197. Biochem Pharmacol. 2015 Feb 1;93(3):290-304 - PubMed
  198. Oncotarget. 2014 Dec 30;5(24):12472-508 - PubMed
  199. Oncoimmunology. 2014 Jul 03;3(7):e944047 - PubMed
  200. EMBO J. 2015 Apr 1;34(7):856-80 - PubMed
  201. Oncotarget. 2015 Feb 28;6(6):4467-81 - PubMed
  202. Immunol Lett. 2015 Apr;164(2):65-71 - PubMed
  203. Nature. 2015 Apr 16;520(7547):373-7 - PubMed
  204. Cancer Res. 2015 Apr 15;75(8):1603-14 - PubMed
  205. Science. 2015 Apr 3;348(6230):56-61 - PubMed
  206. Science. 2015 Apr 3;348(6230):69-74 - PubMed
  207. Oncogene. 2016 Jan 14;35(2):261-8 - PubMed
  208. Angew Chem Int Ed Engl. 2015 May 26;54(22):6483-7 - PubMed
  209. Semin Cancer Biol. 2015 Aug;33:74-85 - PubMed
  210. Nature. 2015 May 7;521(7550):94-8 - PubMed
  211. Oncoimmunology. 2014 Dec 13;3(9):e955691 - PubMed
  212. Oncoimmunology. 2015 Apr 02;4(3):e989771 - PubMed
  213. Nat Med. 2015 May;21(5):431-9 - PubMed
  214. Front Immunol. 2015 Apr 24;6:187 - PubMed
  215. Oncoimmunology. 2015 Jan 7;3(12):e968434 - PubMed
  216. Cancer Res. 2015 Sep 15;75(18):3812-22 - PubMed
  217. Science. 2015 Jul 31;349(6247):1261669 - PubMed
  218. J Clin Invest. 2015 Sep;125(9):3413-21 - PubMed
  219. Oncotarget. 2015 Sep 29;6(29):26841-60 - PubMed
  220. Int J Dev Biol. 2015;59(1-3):131-40 - PubMed
  221. Radiat Oncol. 2015 Sep 17;10:197 - PubMed
  222. Mol Cancer. 2015 Sep 24;14:174 - PubMed
  223. Autophagy. 2015;11(10):1878-90 - PubMed
  224. Oncoimmunology. 2015 Aug 12;5(2):e1069938 - PubMed
  225. Oncoimmunology. 2015 Sep 11;5(2):e1083669 - PubMed
  226. Mol Cell Oncol. 2014 Dec 01;2(1):e975089 - PubMed
  227. Radiother Oncol. 1986 Jul;6(3):167-84 - PubMed
  228. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;82(2):133-42 - PubMed
  229. J Exp Med. 1982 Jan 1;155(1):264-75 - PubMed
  230. Br J Cancer Suppl. 1980 Apr;4:1-10 - PubMed
  231. Natl Cancer Inst Monogr. 1982 Jun;61:183-92 - PubMed
  232. Natl Cancer Inst Monogr. 1978 Dec;(49):97-100 - PubMed
  233. J Exp Med. 1995 Nov 1;182(5):1545-56 - PubMed
  234. Int J Cancer. 1995 Apr 10;61(2):272-9 - PubMed
  235. Br J Cancer. 1995 Mar;71(3):549-55 - PubMed
  236. J Biol Chem. 1994 Oct 7;269(40):25106-19 - PubMed
  237. Annu Rev Immunol. 1994;12:991-1045 - PubMed
  238. Transplantation. 1994 Jan;57(2):211-7 - PubMed
  239. J Photochem Photobiol B. 1996 Nov;36(2):113-9 - PubMed
  240. J Biol Chem. 1997 Oct 17;272(42):26159-65 - PubMed
  241. Nat Med. 1998 May;4(5):581-7 - PubMed
  242. Lab Invest. 1998 May;78(5):603-17 - PubMed
  243. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12322-7 - PubMed
  244. Anticancer Res. 1998 Nov-Dec;18(6B):4651-4 - PubMed

Publication Types